Cyclic GMP inhibits cytoplasmic Ca2+ oscillation by increasing Ca2+-ATPase activity in rat megakaryocytes

European Journal of Pharmacology
C UneyamaM Takahashi

Abstract

The regulatory effects of cyclic GMP on purinoceptor-operated cytoplasmic Ca2+ oscillation of rat megakaryocytes were investigated by using whole-cell patch-clamp technique. ATP-induced oscillatory K+ currents though Ca2+-activated K+ channels (I(KCa)S) were depressed by pretreatment with the guanylate cyclase activator, sodium nitroprusside, and a stable membrane-permeable cGMP analogue, 8-bromo-cGMP. The inhibition by sodium nitroprusside was blocked by treatment with a cyclic nucleotide-dependent protein kinase inhibitor, N-[2-(methylamino)]-5-isoquinolinesulfonamide x HCl (H-8) (10 microM), but not by a selective cAMP-dependent-protein kinase inhibitor, Rp-cAMPS (100 microM). The oscillatory I(KCa) directly evoked by intracellular D-myo-inositol-trisphosphate (IP3) perfusion was also inhibited by the application of sodium nitroprusside. The inhibitory effect of sodium nitroprusside disappeared when the ATP-induced oscillatory I(KCa) was changed to a monophasic sustained I(KCa) current by inhibition of Ca2+-ATPase. These results suggested that cGMP depressed Ca2+ mobilization by improving Ca2+-ATPase activity by phosphorylation.

References

Feb 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J GeigerU Walter
Sep 24, 1991·Biochimica Et Biophysica Acta·M G DoniA Alexandre
Aug 1, 1988·The Journal of General Physiology·R Horn, A Marty
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Aug 18, 1993·Biochimica Et Biophysica Acta·H H SchmidtU Walter
Aug 1, 1993·British Journal of Pharmacology·N AkaikeY Yamashita
Jun 6, 1995·Biochemical and Biophysical Research Communications·C UneyamaM Takahashi
Aug 16, 1994·European Journal of Pharmacology·C UneyamaN Akaike
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P RuthF Hofmann
Jan 1, 1995·Advances in Pharmacology·L J McDonald, F Murad
Jan 1, 1995·Advances in Pharmacology·T M LincolnT L Cornwell
Jan 1, 1996·Proceedings of the Society for Experimental Biology and Medicine·L J McDonald, F Murad
Nov 30, 1995·European Journal of Pharmacology·C UneyamaN Akaike
Jan 29, 1997·European Journal of Pharmacology·C UneyamaN Akaike

❮ Previous
Next ❯

Citations

May 6, 2008·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Saisudha KokaFlorian Lang
Feb 9, 2000·American Journal of Physiology. Cell Physiology·A S GukovskayaS J Pandol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.